Evolving therapies for the treatment of HCV viral hepatitis
ACS Med Chem Lett
.
2014 Mar 13;5(3):212-3.
doi: 10.1021/ml500064y.
Author
George Painter
1
Affiliation
1
CEO, DRIVE-Drug Innovation Ventures at Emory, LLC.
PMID:
24900816
PMCID:
PMC4027607
DOI:
10.1021/ml500064y
No abstract available